• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    AtriCure, Inc. - Common Stock (NQ:ATRC)

    28.79 +0.38 (+1.34%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Jun 12, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 700,874
    Open 28.46
    Bid (Size) 27.04 (2,000)
    Ask (Size) 31.00 (200)
    Prev. Close 28.41
    Today's Range 28.16 - 28.91
    52wk Range 25.36 - 43.18
    Shares Outstanding 45,882,449
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    AtriCure to Participate in the Goldman Sachs 47th Annual Global Health Care Conference
    From AtriCure, Inc.
    Via Business Wire
    News headline image
    AtriCure Conference: New Devices, EnCompass Drive 2026 Growth Outlook ↗
    AtriCure (NASDAQ:ATRC) executives said the company’s 2026 revenue outlook is being supported by recent and upcoming product launches, continued adoption of its EnCompass ablation platform and expanding... 
    Via MarketBeat

    Performance

    YTD
    -26.7%
    -26.7%
    1 Month
    +7.9%
    +7.9%
    3 Month
    -2.5%
    -2.5%
    6 Month
    -30.5%
    -30.5%
    1 Year
    -12.8%
    -12.8%

    More News

    Read More
    News headline image
    AtriCure (ATRC) Q1 2026 Earnings Transcript ↗
    Via The Motley Fool
    AtriCure (NASDAQ:ATRC) Q1 Results Beat Estimates as Company Reaches Key Profitability Milestone ↗
    Via Chartmill
    AtriCure Inc (NASDAQ:ATRC) Stock Surges on Q4 2025 Earnings Beat and Profitability Milestone ↗
    Via Chartmill
    Topics Earnings
    News headline image
    AtriCure Reports First Quarter 2026 Financial Results
    From AtriCure, Inc.
    Via Business Wire
    News headline image
    AtriCure to Participate in the 2026 Bank of America Securities Health Care Conference
    From AtriCure, Inc.
    Via Business Wire
    News headline image
    AtriCure to Announce First Quarter 2026 Financial Results
    From AtriCure, Inc.
    Via Business Wire
    News headline image
    This Biotech Stock Winner Is Up 72%, but a $4 Million Trim Signals a Slight Reset ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    This $6.5 Million Healthcare Trim Comes Amid a 71% Stock Surge and 20% Revenue Growth ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    This $8.9 Million Buy Targets a Stock Down 68% With $322 Million in Cash ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    DAFNA Capital Trims iShares Biotechnology ETF Within Broader Biotech Portfolio, According to Recent SEC Filing ↗
    Via The Motley Fool
    Topics Derivatives ETFs Regulatory Compliance
    News headline image
    AtriCure CSO Sells 5,000 Shares — A Modest Trim or a Pattern Worth Watching? ↗
    Via The Motley Fool
    Topics Derivatives Regulatory Compliance
    News headline image
    AtriCure to Participate in the Citizens Life Sciences Conference
    From AtriCure, Inc.
    Via Business Wire
    News headline image
    AtriCure (ATRC) Q4 2025 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    News headline image
    AtriCure Reports Fourth Quarter 2025 and Full Year 2025 Financial Results
    From AtriCure, Inc.
    Via Business Wire
    News headline image
    AtriCure to Announce Fourth Quarter and Full Year 2025 Financial Results
    From AtriCure, Inc.
    Via Business Wire
    News headline image
    AI Diagnostics: The End of the High-Cost Imaging Era
    From Equity Insider
    Via GlobeNewswire
    What's going on in today's pre-market session ↗
    Via Chartmill
    News headline image
    AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2025, Provides Financial Outlook for 2026
    From AtriCure, Inc.
    Via Business Wire
    News headline image
    AtriCure to Participate in the J.P. Morgan 44th Annual Healthcare Conference
    From AtriCure, Inc.
    Via Business Wire
    News headline image
    AtriCure Announces the First Patients Treated with Novel Dual Energy Platform
    From AtriCure, Inc.
    Via Business Wire
    News headline image
    Is AtriCure Stock a Buy or Sell After a Director Dumped 10,000 Shares? ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    AtriCure to Participate in the Piper Sandler 37th Annual Healthcare Conference
    From AtriCure, Inc.
    Via Business Wire
    News headline image
    AtriCure (ATRC) Q3 2025 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings

    Frequently Asked Questions

    Is AtriCure, Inc. - Common Stock publicly traded?
    Yes, AtriCure, Inc. - Common Stock is publicly traded.
    What exchange does AtriCure, Inc. - Common Stock trade on?
    AtriCure, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for AtriCure, Inc. - Common Stock?
    The ticker symbol for AtriCure, Inc. - Common Stock is ATRC on the Nasdaq Stock Market
    What is the current price of AtriCure, Inc. - Common Stock?
    The current price of AtriCure, Inc. - Common Stock is 28.79
    When was AtriCure, Inc. - Common Stock last traded?
    The last trade of AtriCure, Inc. - Common Stock was at 06/12/26 04:00 PM ET
    What is the market capitalization of AtriCure, Inc. - Common Stock?
    The market capitalization of AtriCure, Inc. - Common Stock is 1.32B
    How many shares of AtriCure, Inc. - Common Stock are outstanding?
    AtriCure, Inc. - Common Stock has 1B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.